Utz, Begüm
Turpin, Rita
Lampe, Johanna
Pouwels, Jeroen
Klefström, Juha
Funding for this research was provided by:
Doctoral Programme in Integrative Life Science
Academy of Finland
Business Finland
K. Albin Johanssons Stiftelse
Horizon 2020 Framework Programme (847912)
Juselius Foundation
Breast Cancer Now
Syöpäsäätiö
iCAN Digital Precision Cancer Medicine Flagship
Article History
Received: 25 February 2020
Accepted: 15 October 2020
First Online: 30 October 2020
Competing interests
: Dr. Klefstrom’s research projects have received funding from AbbVie, Orion Pharma and Roche/Genentech. Dr. Klefstrom has served as a member of scientific advisory board or consultant to AbbVie, Orion Pharma and Roche/Genentech. Dr. Lampe and Dr. Pouwels have consulted for Biomedicum Genomics. Other authors declare no conflics of interest.